focus trial semaglutide Excited to be featured in Forbes Health discussing the remarkable cardiovascular benefits of Ozempic (semaglutide)! A 20% reduction in risk for heart attack, stroke, or death due to cardiovascular disease is a Frontiers | Safety of Semaglutide

Mounjaro (tirzepatide), a newer dual GIP/GLP-1 receptor agonist, has shown comparable hair loss patterns in clinical trials, with approximately 5-6% of participants reporting alopecia as a side effect during periods of drastic weight loss [3]

modelling, visual predictive checks over each trial and across trials, mean model predictions across trial arms and individual fits over time

Three-dimensional modelling for estimation of nevus count and probability of nevus-melanoma progression in a murine model

This means your body has a harder time metabolizing blood sugar

The way we believe we can optimize performance is through transparency, clinically effective doses, and clinically proven ingredients with evidence-based outcomes